Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Barry Douglas Anderson
The Role of Age on Dose-Limiting Toxicities (DLTs) in Phase I Dose-Escalation Trials.
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Related publications
Correction: The Impact of Non-Drug-Related Toxicities on the Estimation of the Maximum Tolerated Dose in Phase I Trials
Clinical Cancer Research
Cancer Research
Oncology
Operating Characteristics of Restrictions on Skipping Dose Level for Adaptive Dose-Finding Method in Two-Agent Phase I Trials
Japanese Journal of Biometrics
A Phase I/Ii Seamless Dose Escalation/Expansion With Adaptive Randomization Scheme (SEARS)
Clinical Trials
Medicine
Pharmacology
Relationship Between Response and Dose in Published, Contemporary Phase I Oncology Trials
Journal of the National Comprehensive Cancer Network : JNCCN
Medicine
Oncology
Escalation Strategies for Combination Therapy Phase I Trials
Pharmaceutical Statistics
Statistics
Probability
Pharmacology
A Dose-Schedule Finding Design for Phase I-Ii Clinical Trials
Journal of the Royal Statistical Society. Series C: Applied Statistics
Uncertainty
Statistics
Probability
Phase I Dose-Escalation Study and Biomarker Analysis of E7080 in Patients With Advanced Solid Tumors
Clinical Cancer Research
Cancer Research
Oncology
A Phase I Dose-Escalation Study of Intravenous Panobinostat in Patients With Lymphoma and Solid Tumors
Investigational New Drugs
Oncology
Pharmacology
A Phase I Dose-Escalation Study of a Biosimilar Trastuzumab in Chinese Metastasis Breast Cancer Patients
SpringerPlus
Multidisciplinary